Clinical trial
THERApy De-escalation for TESTicular Cancer
NCT06309745 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- THERApy De-escalation for TESTicular Cancer
- Lead sponsor
- Queen Mary University of London
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 24, 2024
- Completion date
- October 2, 2028
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.